Teva Pharmaceutical and IBM Watson Health have announced a strategic partnership whereby Teva will be the first global pharmaceutical company to tap the power of the Watson Health Cloud.
Teva plans to use the IBM Watson Health Cloud platform to develop e-health solutions for patients with chronic conditions such as asthma, pain, migraine and neurodegenerative diseases.
The IBM Watson Health Cloud is able to create a secure, cloud-based data sharing platform, powered by advanced cognitive and analytic technologies meant to improve efficiency and organization.
Launched in April, IBM's new business unit offers cloud-based access to its Watson supercomputer for analyzing healthcare data. IBM has partnered with Apple, Johnson & Johnson and Medtronic on the project.
Read the press release